In early February, the U.S. Federal Trade Commission published a proposed order that fines telehealth and discount prescription provider GoodRX $1.5 milllion. Though part of the case involves deception – one of two prongs under the FTC Act – the case also raises the first-of-its-kind use of the Health Breach Notification Rule. To help better understand the novel and complex issues that are embedded in the case, IAPP Editorial Director Jedidiah Bracy caught up with Wilmer Hale Partner Kirk Nahra to discuss some of the takeaways privacy pros in any industry vertical should consider.
Inside the EU AI Act negotiations: A discussion with Laura Caroli
Top trends in cybersecurity: A chat with James Dempsey and John Carlin
Regulating AI in the UK: A discussion with Lord Holmes
Privacy and data protection in 2023: A year in review with Joe Jones
Luca Bertuzzi on the EU AI Act political deal and what's next
Martin Abrams: A look back at a career in information privacy and consumer policy
EU policymakers discuss the EU AI Act negotiations at DPC23
Catching up with the co-author of the White House Blueprint for an AI Bill of Rights
Assessing the Snowden revelations 10 years later
The ins and outs of workplace privacy law: A chat with Zoe Argento
NIST's Reva Schwartz on the new AI Risk Management Framework
A look at privacy developments in 2023 with Omer Tene
All things 'California Privacy Law' with Lothar Determann
Operationalizing data subject rights: How Consumer Reports is aiming to help
The EU AI Act: A discussion with MEP and Co-rapporteur Dragoș Tudorache
What the 2022 midterm election results mean for US privacy law
On the need for intimate privacy - A chat with Danielle Citron
A chat with U.K. Information Commissioner John Edwards
Children's privacy and safety: A conversation with Kalinda Raina
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Reaching your Goals
Insights@work
Business Dad
The Ken Coleman Show
The Cardone Zone